C-reactive protein and other markers of inflammation in hemodialysis patients

نویسنده

  • Behzad Heidari
چکیده مقاله:

Background: Hemodialysis patients are at greater risk of cardiovascular disease. Higher than expected cardiovascular morbidity and mortality in this population has been attributed to dislipidemia as well as inflammation. The causes of inflammation in hemodialysis patients are multifactorial. Several markers were used for the detection of inflammatory reaction in patients with chronic renal disease. These markers can be used for the prediction of future cardiovascular events. Among the several parameters of inflammatory markers, serum, CRP is well known and its advantages for the detection of inflammation and its predictor ability has been evaluated in several studies. This review addressed the associated factors and markers of inflammation in hemodialysis patients. In addition, their ability in predicting future atherosclerosis and effect of treatment has been reviewed. However, this context particularly in using CRP as a prediction marker of inflammation and morbidity requires further studies.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

c-reactive protein and other markers of inflammation in hemodialysis patients

background: hemodialysis patients are at greater risk of cardiovascular disease. higher than expected cardiovascular morbidity and mortality in this population has been attributed to dislipidemia as well as inflammation. the causes of inflammation in hemodialysis patients are multifactorial. several markers were used for the detection of inflammatory reaction in patients with chronic renal dise...

متن کامل

C-reactive protein and other markers of inflammation in hemodialysis patients.

Hemodialysis patients are at greater risk of cardiovascular disease. Higher than expected cardiovascular morbidity and mortality in this population has been attributed to dislipidemia as well as inflammation. The causes of inflammation in hemodialysis patients are multifactorial. Several markers were used for the detection of inflammatory reaction in patients with chronic renal disease. These m...

متن کامل

The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is a condition associated with inflammation in lungs and airways. The impacts of inflammatory process is not limited to respiratory system but extend to extrapulmonary organs with resultant complications involving endocrine, metabolic and cardiovascular systems. The extent and severity of inflammation may be partly estimated by serum measurement of s...

متن کامل

association between serum c- reactive protein levels and other important predictive markers of outcome in copd

c-reactive protein (crp) is an acute-phase protein synthesized predominantly by the hepatocytes in response to tissue damage or inflammation. levels of acute-phase proteins rise rapidly, during infection and after injury. we take up the study to correlate serum crp levels with other important predictive markers of outcome in copd. patient with stable copd (no exacerbation in the last two months...

متن کامل

the importance of c-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease

chronic obstructive pulmonary disease (copd) is a condition associated with inflammation in lungs and airways. the impacts of inflammatory process is not limited to respiratory system but extend to extrapulmonary organs with resultant complications involving endocrine, metabolic and cardiovascular systems. the extent and severity of inflammation may be partly estimated by serum measurement of s...

متن کامل

Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women.

Although increased levels of C-reactive protein have been linked to E therapy, the significance of this finding and whether it occurs with the selective ER modulators are unknown. Thirty-five healthy postmenopausal women were enrolled in a placebo-controlled, two-period cross-over design trial to evaluate the effects of 0.625 mg oral conjugated E and 60 mg droloxifene, a structural analog of ta...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


عنوان ژورنال

دوره 4  شماره None

صفحات  611- 616

تاریخ انتشار 2013-01

با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023